{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1818 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "10059636", "primarysourcecountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141212", "reporttype": "1", "serious": "1", "seriousnessdeath": "1", "receivedateformat": "102", "receivedate": "20140402", "receiptdateformat": "102", "receiptdate": "20140402", "fulfillexpeditecriteria": "1", "companynumb": "ADR-2014UNK001", "duplicate": "1", "reportduplicate": { "duplicatesource": "SCIEGEN", "duplicatenumb": "ADR-2014UNK001" }, "primarysource": { "reportercountry": "US" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "140", "patientonsetageunit": "804", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Ascites" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Oligohydramnios" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Neural tube defect" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Maternal drugs affecting foetus" }, { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Foetal death" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "NEVIRAPINE", "drugauthorizationnumb": "203176", "drugstructuredosagenumb": "400", "drugstructuredosageunit": "003", "drugadministrationroute": "048", "drugindication": "ACQUIRED IMMUNODEFICIENCY SYNDROME", "openfda": { "application_number": [ "ANDA077702", "ANDA077521", "ANDA078584", "ANDA202523", "ANDA090688", "ANDA078195", "ANDA206879", "ANDA203080", "ANDA205651" ], "brand_name": [ "NEVIRAPINE" ], "generic_name": [ "NEVIRAPINE" ], "manufacturer_name": [ "Aurobindo Pharma Limited", "Camber Pharmaceuticals, Inc.", "Mylan Pharmaceuticals Inc.", "Macleods Pharmaceuticals Limited", "Amneal Pharmaceuticals LLC", "Micro Labs Limited" ], "product_ndc": [ "65862-057", "65862-027", "31722-505", "0378-4050", "33342-004", "65162-209", "33342-238", "42571-131", "0378-4890" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "NEVIRAPINE HEMIHYDRATE", "NEVIRAPINE" ], "rxcui": [ "311943", "199422", "1095712" ], "spl_id": [ "fd37e474-7411-4466-bf46-36fc74ef6684", "0f465f42-d781-453e-ac8c-f5017bf06fe1", "e5515515-0ee0-e288-e053-2995a90a3d7c", "9eeacada-81f4-48c6-b924-515efdb2b219", "99d52ed2-f3e5-476a-8ba6-ed2cee3aae8a", "fd384f73-fd86-4750-8d30-ecbb4289572a", "de3914b8-5c5c-4b11-a9f9-39f592d51c1d", "41535937-97d5-fb3f-e063-6294a90afa9e", "750bda83-d972-44e2-85ae-26676e1e7c34" ], "spl_set_id": [ "8dfe86aa-ea5d-48d2-94a8-1a5506055d70", "5f6c3eed-2a5d-46ed-9a7c-59715f338a15", "61409678-d2f6-42cd-b03d-b26b11b39641", "c6e93829-7024-48f6-8023-da6ff27dfc0a", "effb86cc-4b80-4fac-aaa3-9f373b3d0f7d", "4f065674-4719-4c79-ba0d-549040d77f17", "2620b114-f53f-44f1-8708-697e86343090", "fbd628db-4076-4fe0-8323-9cc33ae92e42", "690da74b-2481-47fc-93ae-8340e0caf0a4" ], "package_ndc": [ "65862-057-11", "65862-057-24", "65862-027-60", "65862-027-10", "31722-505-60", "31722-505-01", "31722-505-05", "31722-505-10", "0378-4050-91", "33342-004-09", "65162-209-06", "33342-238-07", "42571-131-60", "42571-131-29", "0378-4890-93" ], "unii": [ "B7XF2TD73C", "99DK7FVK1H" ], "nui": [ "N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064" ], "pharm_class_epc": [ "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]" ], "pharm_class_moa": [ "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]" ] } }, { "drugcharacterization": "1", "medicinalproduct": "NA", "openfda": { "application_number": [ "M", "NDA212319", "NDA216359", "ANDA208824" ], "brand_name": [ "MG DERMACLEAN", "N/A", "HEALTHY HANDS FOAMING HAND SANITIZER", "MG DERMASAN" ], "generic_name": [ "N/A", "ATROPINE SULFATE INJECTION USP, 0.5 MG/0.7 ML", "ATROPINE SULFATE INJECTION USP, 1 MG/0.7 ML", "ATROPINE INJECTION, 2 MG", "MIDAZOLAM INJECTION, 10 MG", "TADALAFIL" ], "manufacturer_name": [ "Morgan Gallacher Inc.", "Rafa Laboratories, Ltd.", "Bostal LLC", "Maintex" ], "product_ndc": [ "50241-014", "71053-590", "71053-591", "71053-592", "71053-595", "35561-254", "35561-255", "35561-256", "35561-257", "77617-001", "50241-259" ], "product_type": [ "HUMAN OTC DRUG", "HUMAN PRESCRIPTION DRUG" ], "route": [ "TOPICAL", "INTRAMUSCULAR", "ORAL" ], "substance_name": [ "BENZALKONIUM CHLORIDE", "ATROPINE", "MIDAZOLAM", "TADALAFIL" ], "rxcui": [ "1046593", "1190538", "1190540", "1190542", "2608698", "402019", "403957", "484814", "757707", "1038799", "1038791" ], "spl_id": [ "da16e124-7b03-48f6-a245-c37b9b67fe14", "4b1cda4c-c117-7a42-e063-6294a90a14e2", "4b1cba4c-3cc1-5642-e063-6294a90a4522", "49fc9e85-3dc2-064f-e063-6294a90af582", "a4167526-05d2-48d9-b372-17fe021d80fb", "e2af03cb-3b39-4082-883d-13c72fd5d27f" ], "spl_set_id": [ "ed3d983e-0a6e-4de4-832a-0020f7711011", "4a4fa6e8-0e0a-0e76-e054-00144ff8d46c", "d7362b4d-68a3-99a0-e053-2995a90a4f60", "78509a43-a907-4359-9022-f38c4f765880", "746650b8-74b7-43f0-bdfc-62a68764f936", "d4c0de39-8570-4a05-a5e3-3752545ed95f" ], "package_ndc": [ "50241-014-01", "50241-014-02", "71053-591-01", "71053-590-01", "71053-592-01", "71053-595-01", "35561-254-10", "35561-254-13", "35561-255-10", "35561-255-13", "35561-256-10", "35561-256-13", "35561-257-10", "35561-257-13", "77617-001-01", "77617-001-02", "77617-001-06", "77617-001-05", "50241-259-01", "50241-259-02" ], "unii": [ "F5UM2KM3W7", "7C0697DR9I", "R60L0SM5BC", "742SXX0ICT" ], "nui": [ "N0000175574", "N0000175370", "N0000175700", "N0000000125", "N0000175694", "M0002356", "N0000175599", "N0000020026" ], "pharm_class_epc": [ "Anticholinergic [EPC]", "Cholinergic Muscarinic Antagonist [EPC]", "Benzodiazepine [EPC]", "Phosphodiesterase 5 Inhibitor [EPC]" ], "pharm_class_moa": [ "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonists [MoA]", "Phosphodiesterase 5 Inhibitors [MoA]" ], "pharm_class_cs": [ "Benzodiazepines [CS]" ] } }, { "drugcharacterization": "2", "medicinalproduct": "TRUVADA", "openfda": { "application_number": [ "NDA021752" ], "brand_name": [ "TRUVADA" ], "generic_name": [ "EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE" ], "manufacturer_name": [ "Gilead Sciences, Inc" ], "product_ndc": [ "61958-0701", "61958-0703", "61958-0704", "61958-0705" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "EMTRICITABINE", "TENOFOVIR DISOPROXIL FUMARATE" ], "rxcui": [ "476556", "639888", "1744001", "1744003", "1744005", "1744007", "1744009", "1744011" ], "spl_id": [ "32422ee8-1cdc-4305-bb3e-0458472513fc" ], "spl_set_id": [ "54e82b13-a037-49ed-b4b3-030b37c0ecdd" ], "package_ndc": [ "61958-0701-1", "61958-0703-1", "61958-0704-1", "61958-0705-1" ], "nui": [ "N0000175462", "M0015066", "N0000009947" ], "pharm_class_epc": [ "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]" ], "pharm_class_cs": [ "Nucleosides [CS]" ], "pharm_class_moa": [ "Nucleoside Reverse Transcriptase Inhibitors [MoA]" ], "unii": [ "G70B4ETF4S", "OTT9J7900I" ] } }, { "drugcharacterization": "2", "medicinalproduct": "EPIZICOM" } ] } } ] }